Hsbc Holdings PLC raised its stake in Avantor, Inc. (NYSE:AVTR – Free Report) by 635.0% in the 4th quarter, HoldingsChannel.com reports. The firm owned 218,287 shares of the company’s stock after buying an additional 188,587 shares during the quarter. Hsbc Holdings PLC’s holdings in Avantor were worth $2,514,000 as of its most recent SEC filing.
A number of other large investors also recently modified their holdings of the stock. Private Trust Co. NA boosted its holdings in Avantor by 46.2% during the 4th quarter. Private Trust Co. NA now owns 2,769 shares of the company’s stock worth $32,000 after acquiring an additional 875 shares during the last quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. grew its stake in shares of Avantor by 28.1% in the 3rd quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 4,123 shares of the company’s stock worth $49,000 after acquiring an additional 905 shares in the last quarter. Osaic Holdings Inc. raised its holdings in shares of Avantor by 60.9% in the second quarter. Osaic Holdings Inc. now owns 2,810 shares of the company’s stock valued at $38,000 after purchasing an additional 1,064 shares during the last quarter. UMB Bank n.a. raised its holdings in shares of Avantor by 17.6% in the fourth quarter. UMB Bank n.a. now owns 7,371 shares of the company’s stock valued at $84,000 after purchasing an additional 1,101 shares during the last quarter. Finally, EverSource Wealth Advisors LLC lifted its position in shares of Avantor by 119.1% during the second quarter. EverSource Wealth Advisors LLC now owns 2,187 shares of the company’s stock valued at $29,000 after purchasing an additional 1,189 shares in the last quarter. Institutional investors own 95.08% of the company’s stock.
Avantor Trading Down 2.7%
NYSE:AVTR opened at $10.01 on Tuesday. Avantor, Inc. has a 1 year low of $7.26 and a 1 year high of $15.93. The stock’s fifty day moving average price is $8.74 and its two-hundred day moving average price is $9.49. The company has a debt-to-equity ratio of 0.68, a current ratio of 1.76 and a quick ratio of 1.17. The company has a market cap of $6.83 billion, a P/E ratio of -12.35, a P/E/G ratio of 5.96 and a beta of 0.97.
Insider Transactions at Avantor
In other news, Director Simon Dingemans acquired 25,000 shares of the business’s stock in a transaction dated Friday, May 1st. The stock was bought at an average cost of $8.14 per share, for a total transaction of $203,500.00. Following the completion of the transaction, the director owned 25,000 shares of the company’s stock, valued at $203,500. The trade was a ∞ increase in their ownership of the stock. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link. Also, Director Gregory T. Lucier acquired 10,000 shares of Avantor stock in a transaction that occurred on Friday, May 8th. The shares were purchased at an average cost of $8.32 per share, with a total value of $83,200.00. Following the purchase, the director owned 60,000 shares of the company’s stock, valued at $499,200. This represents a 20.00% increase in their position. Additional details regarding this purchase are available in the official SEC disclosure. 0.28% of the stock is owned by insiders.
Wall Street Analyst Weigh In
Several research firms recently weighed in on AVTR. Wolfe Research cut shares of Avantor to an “underperform” rating and set a $7.00 price target on the stock. in a report on Monday, June 1st. Wall Street Zen upgraded shares of Avantor from a “hold” rating to a “buy” rating in a research note on Saturday. Royal Bank Of Canada started coverage on shares of Avantor in a research report on Thursday, May 14th. They set a “sector perform” rating and a $9.00 target price on the stock. Barclays boosted their target price on Avantor from $7.00 to $8.00 and gave the stock an “underweight” rating in a research note on Wednesday, June 24th. Finally, Zacks Research raised Avantor from a “strong sell” rating to a “hold” rating in a research report on Thursday, April 30th. Two research analysts have rated the stock with a Buy rating, twelve have given a Hold rating and three have issued a Sell rating to the company. Based on data from MarketBeat.com, the stock has a consensus rating of “Reduce” and a consensus target price of $10.47.
View Our Latest Stock Report on AVTR
Avantor Profile
Avantor, Inc (NYSE:AVTR) is a global provider of mission-critical products and services to customers in the biopharma, healthcare, education & government, and advanced technologies & applied materials industries. The company delivers essential solutions that support research, development, production and safety applications. Its product portfolio spans from high-purity chemicals and reagents to biologics and cell culture media, as well as lab equipment, consumables and custom manufacturing services.
Avantor’s offerings are organized across two primary segments.
Featured Articles
- Five stocks we like better than Avantor
- The AI Boom Has a Second Act—And It’s Playing Out in Optics
- Gold’s 2026 Rally Has Cracked—Is It Time to Buy the Pullback?
- 5 Tech Stocks to Buy on the July Pullback
- Is OpenAI’s IPO Delay a Warning for AI Investors?
Want to see what other hedge funds are holding AVTR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Avantor, Inc. (NYSE:AVTR – Free Report).
Receive News & Ratings for Avantor Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Avantor and related companies with MarketBeat.com's FREE daily email newsletter.
